More about

Migraine

News
June 16, 2024
2 min read
Save

Spontaneous intracranial hypotension significantly affects quality of life

Spontaneous intracranial hypotension significantly affects quality of life

SAN DIEGO – Spontaneous intracranial hypotension led to significant physical, mental and quality of life impact for a cohort of those with the condition, according to a speaker at the American Headache Society Annual Scientific Meeting.

News
June 14, 2024
2 min read
Save

AI-based models accurately predict, show promise for expansion in headache

AI-based models accurately predict, show promise for expansion in headache

SAN DIEGO — AI-based models are currently best utilized as a predictor of headache, but show promise for expansion into the health care continuum, according to a speaker at the American Headache Society Annual Scientific Meeting.

News
May 15, 2024
1 min read
Save

Zavegepant nasal spray linked to higher likelihood of pain freedom at 2 hours

Zavegepant nasal spray linked to higher likelihood of pain freedom at 2 hours

DENVER — Treatment with 10 mg zavegepant nasal spray was associated with a higher likelihood of pain freedom compared with placebo at 2 hours post dose, according to a presentation at the American Academy of Neurology annual meeting.

News
May 03, 2024
1 min read
Save

Researchers find potential link between CKD, migraines in Korean adults

Researchers find potential link between CKD, migraines in Korean adults

There may be a link between chronic kidney disease and the onset of migraines in Korean adults, according to data from a nationwide longitudinal follow-up study.

News
April 26, 2024
2 min read
Save

Children from underrepresented groups get fewer migraine diagnoses, tests, imaging

Children from underrepresented groups get fewer migraine diagnoses, tests, imaging

DENVER — Children from underrepresented groups with migraine received fewer diagnoses, imaging, tests and medication compared with their white counterparts, according to a poster at the American Academy of Neurology annual meeting.

News
April 18, 2024
1 min read
Save

Concomitant use of atogepant, ubrogepant for migraine safe over 12 weeks

Concomitant use of atogepant, ubrogepant for migraine safe over 12 weeks

DENVER — The concomitant use of atogepant for preventive and ubrogepant for acute migraine treatment was found to be safe and well-tolerated over 12 weeks, according to research presented at the American Academy of Neurology annual meeting.

News
April 16, 2024
2 min read
Save

Headache associated with attempted, completed suicide

Headache associated with attempted, completed suicide

DENVER — Among a large cohort of Danish citizens, headache disorders were strongly associated with attempted and completed suicide, according to a presenter at the American Academy of Neurology annual meeting.

News
March 26, 2024
2 min read
Save

Migraine, nontraditional factors likely contribute to stroke risk in young adults

Migraine, nontraditional factors likely contribute to stroke risk in young adults

Nontraditional risk factors such as migraine, valvular heart disease and thrombophilia may be linked to increased risk for stroke among younger adults, researchers reported.

News
February 20, 2024
2 min read
Save

Migraine plus persistent vasomotor symptoms linked to greater stroke, CVD risks

Migraine plus persistent vasomotor symptoms linked to greater stroke, CVD risks

Migraine plus persistent vasomotor symptoms is associated with greater CVD risk and stroke for women, according to a secondary data analysis published in Menopause.

News
February 12, 2024
8 min read
Save

Direct-to-consumer model may improve drug access, but providers warn about possible biases

Direct-to-consumer model may improve drug access, but providers warn about possible biases

A new direct-to-consumer health care program launched by Eli Lilly has the potential to improve access to diabetes, obesity and migraine medications in the United States.

View more